<DOC>
	<DOCNO>NCT00002767</DOCNO>
	<brief_summary>RATIONALE : Interferon alfa may interfere growth cancer cells.Vaccines may make body build immune response kill tumor cell . It yet know whether melanoma vaccine plus interferon alfa effective interferon alfa alone treat patient metastatic melanoma . PURPOSE : Randomized phase III trial compare effectiveness interferon alfa without vaccine therapy treat patient metastatic melanoma .</brief_summary>
	<brief_title>Interferon Alfa With Without Vaccine Therapy Treating Patients With Metastatic Melanoma</brief_title>
	<detailed_description>OBJECTIVES : I . Compare survival follow immunotherapy allogeneic melanoma vaccine plus interferon alfa-2b ( IFN-A ) vs. IFN-A alone patient metastatic melanoma . II . Assess safety toxicity immunotherapy allogeneic melanoma vaccine plus IFN-A patient . III . Compare frequencies durable complete response treatment group . IV . Compare overall clinical objective response , duration response , time disease progression treatment group . V. Compare effect immunotherapy allogeneic melanoma vaccine plus IFN-A vs IFN-A alone quality life patient . OUTLINE : This randomize , multicenter study . Patients stratify location metastatic site ( visceral bone v nonvisceral lung ) number metastatic site ( 1 vs 2 v 3 ) . Patients randomize one two treatment arm . Arm I : Patients receive allogenic melanoma cell lysate vaccine detoxify endotoxin subcutaneously ( SQ ) weekly week 1-5 8-12 . Interferon alfa ( IFN-A ) SQ administer three time week begin week 4 . Patients respond stable disease receive vaccine monthly begin week 16 . IFN-A continue absence disease progression unacceptable toxicity . Arm II : Patients receive IFN-A SQ three time week begin week 1 . Treatment continue absence disease progression unacceptable toxicity . Quality life assess , , treatment . Patients follow every 3 month . PROJECTED ACCRUAL : Approximately 300 patient enter 2 year .</detailed_description>
	<mesh_term>Melanoma</mesh_term>
	<mesh_term>Interferons</mesh_term>
	<mesh_term>Interferon-alpha</mesh_term>
	<mesh_term>Detox adjuvant</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm malignant melanoma metastatic ( pT , N , M1 AJCC stag ) Measurable disease physical exam noninvasive radiologic procedure No concurrent prior diagnosis ocular melanoma No CNS metastases No patient render NED surgery unless patient decline surgery PATIENT CHARACTERISTICS : Age : 18 Performance status : ECOG 0 1 Life expectancy : At least 4 month Hematopoietic : Absolute granulocyte count least 1,500/mm3 Platelet count least 100,000/mm3 Hepatic : Bilirubin great 2 mg/dL AST ALT great 3 time normal No evidence hepatic failure No active hepatitis Renal : Creatinine clearance least 40 mL/min Cardiovascular : No myocardial infarction within 6 month No decompensating congestive heart failure No unstable angina No current symptomatic arrhythmia Other : No known HIV antibody No thyroid abnormality uncontrollable medication No medical , sociological , psychological impediment study compliance No preexist psychiatric condition ( especially depression ) history severe psychiatric disorder No autoimmune disease ( e.g. , systemic lupus erythematosus , multiple sclerosis , ankylose spondylitis ) No concurrent malignancy except nonmelanomatous skin cancer Not pregnant nursing Negative pregnancy test Effective contraception require fertile woman No history egg allergy PRIOR CONCURRENT THERAPY : Biologic therapy : At least 12 month since interferon alfa melanoma vaccine No prior immunotherapy metastatic disease No concurrent cytokine levamisole Chemotherapy : No prior chemotherapy metastatic disease At least 4 month since adjuvant therapy No concurrent chemotherapy Endocrine therapy : At least 1 week since corticosteroid No concurrent immunosuppressive ( e.g. , azathioprine cyclosporine ) Radiotherapy : Prior radiotherapy metastatic disease allow Surgery : See Disease Characteristics Prior surgery metastatic disease allow</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2007</verification_date>
	<keyword>stage IV melanoma</keyword>
	<keyword>recurrent melanoma</keyword>
</DOC>